Abstract:Abstract Impaired expression of antimicrobial peptides α defensins and overproduction of proinflammatory cytokine IL-1β have been associated with inflammatory bowel disease (IBD). In this study, we examine the interactions between defensins and IL-1β and the role of defensin-deficiency in the pathogenesis of IBD. It was found that matrix metalloproteinase-7 deficient (MMP-7−/−) mice, which produce procryptdins but not mature cryptdins (α-defensins) in the intestine, were more susceptible to dextran sulfate sodium (DSS)-induced colitis. Furthermore, the baseline and DSS-induced IL-1β production in the intestine are significantly up-regulated in MMP-7−/− mice compared with that in WT mice. To elucidate the molecular mechanism for the increased IL-1β production in defensin-deficiency in vivo, we evaluated the effect of defensins on IL-1β posttranslational processing and release. It was found that α defensins, including human neutrophil defensin HNP-1, human Paneth cell defensin HD-5, and mouse Paneth cell defensins cryptdin-3 and cryptdin-4, can block the release of IL-1β from LPS-activated monocytes. However, TNF α expression and release from LPS-activated monocytes are not affected by defensins. Unlike α defensins, human β defensins and mouse procryptdins do not have any effect on IL-1β processing and release. Thus, α-defensins may play an important role in intestinal homeostasis by controlling the production of IL-1β.

Regulation of IL-1beta Secretion by Defensins (100.11)